<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="6343" whole_study_id="6343" phs="000583" v="1" p="1" createDate="2010-07-23T15:40:04-05:00" completedByGPADate="2014-03-13T13:34:01-05:00" modDate="2022-02-16T17:13:05-05:00" maxParentChildStudyModDate="2022-02-16T17:13:05-05:00" handle="T2D_AsianIndians" num_participants="2030"><StudyInfo accession="phs000583.v1.p1" parentAccession="phs000583.v1.p1"><BioProject id="PRJNA186401" entrez_id="186401" type="bp_admin_access"/><BioProject id="PRJNA186402" entrez_id="186402" type="bp_data_submission"/><StudyNameEntrez>GWAS to identify risk genes for type 2 diabetes in Asian Indians</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="Yes"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType></StudyTypes><Funding>DK082766</Funding></StudyInfo><Authority><ICs><IC id="11" name="NIDDK" is_funding_ic="false" is_admin_ic="false" primary="true"/><IC id="15" name="NHGRI" is_funding_ic="false" is_admin_ic="false"/></ICs><Persons><Person nedid="DKSANGHERA" aid="2" auth="eRA" login="DKSANGHERA" fname="Dharambir" mname="K" lname="Sanghera" email="dharambir-sanghera@ouhsc.edu"><Role>PI</Role><Organization>UNIVERSITY OF PITTSBURGH AT PITTSBURGHUNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR</Organization></Person><Person nedid="0010693178" aid="1" auth="cit" login="akolkarb" fname="Beena" mname="G" lname="Akolkar" email="akolkarb@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0013043239" aid="1" auth="cit" login="pretels" fname="Renate" mname="S" lname="Pretel" email="pretels@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2003219528" aid="1" auth="cit" login="pawlikowskals" fname="Ludmila" mname="Sylwia" lname="Pawlikowska" email="ludmila.pawlikowska@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>The Sikh Diabetes Study (SDS) was conducted by the University of Oklahoma Health Sciences Center&#8217;s investigative team led by Dr. Dharambir Sanghera  and supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The data from the SDS reported here were supplied by the SDS investigators. This manuscript was not prepared in collaboration with Investigators of the SDS and does not necessarily reflect the opinions or views of the SDS investigators or the NIDDK.</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="contr_access_timeout_extend" gsr_mode_label="Controlled-access (institution requested additional time)"/><ConsentGroup uid="647" CGType="cg_class_other" title="Type 2 diabetes and metabolic syndrome" name="T2DMS" dac_uid="60" dac_name="NIDDK" irb-approval-required="Yes"><Use-Restriction>Use of the dataset is limited to type 2 diabetes and metabolic syndrome research purposes including applications proposing analytical methods, software or other research tool development related to prevetion and treatment of these diseases.</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>